BLTE — Belite Bio Inc
$6.0B market cap · 2 upcoming readouts tracked
Clinical trial readout dates for Belite Bio Inc, compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is June 2027 .
Next readout June 2027 in ~7 months
Upcoming readouts 2 2 Phase 3
Market cap $6.0B
Upcoming readouts Phase 3 Tinlarebant June 2027Ongoing
Phase 2/3 Tinlarebant February 2028Ongoing
Companies working on similar indications
Discussion No messages yet. If you follow BLTE, you can start the conversation.
Track BLTE in real time
See live implied volatility for
BLTE and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on BLTE
Trial data from ClinicalTrials.gov
(U.S. National Library of Medicine); filings and reported financials from
SEC EDGAR — U.S. government
works in the public domain. Dates are study-reported primary completion dates,
which routinely shift and are not results-release dates. Information only, not
investment advice.